Together with Bencard Allergie GmbH, Munich, Germany, ClinCompetence Cologne publishes the top line results of the first year of the 5-years cohort study TAPAS (Tyrosine Allergoid paediatric and adult study)

The TAPAS study (“Tyrosine Allergoid Paediatric and Adult Study”) is a large, prospective, multicenter, long-term cohort study designed to evaluate the safety, tolerability, and efficacy of subcutaneous allergen immunotherapy (SCIT) with microcrystalline tespecially in children, have been lacking.

References